Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Bengt Smedmyr"'
Autor:
Piotr Kozlowski, Maria Åström, Lucia Ahlberg, Per Bernell, Erik Hulegårdh, Hans Hägglund, Karin Karlsson, Alicja Markuszewska-Kuczymska, Beata Tomaszewska-Toporska, Bengt Smedmyr, Helene Hallböök
Publikováno v:
Haematologica, Vol 97, Iss 9 (2012)
Background A minority of patients with adult acute lymphoblastic leukemia who relapse are rescued. The aim of this population-based study was to assess the results of reinduction treatment and allogeneic stem cell transplantation in patients in secon
Externí odkaz:
https://doaj.org/article/b47cd69e243e4bfcb5252925072e1fed
Autor:
Hareth Nahi, Hans Hägglund, Thomas Ahlgren, Per Bernell, Mats Hardling, Karin Karlsson, Vladimir Lj Lazarevic, Mats Linderholm, Bengt Smedmyr, Maria Åström, Helene Hallböök
Publikováno v:
Haematologica, Vol 93, Iss 11 (2008)
In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with
Externí odkaz:
https://doaj.org/article/12feaa15141a48e7b4472e26b540cca4
Autor:
Piotr Kozlowski, Alicja Markuszewska-Kuczymska, Karin Karlsson, Hans Hägglund, Helene Hallböök, Maria Åström, Rose-Marie Amini, Erik Hulegårdh, Bengt Smedmyr, Per Bernell, Beata Tomaszewska-Toporska, Lucia Ahlberg
Publikováno v:
European Journal of Haematology. 92:377-381
Background Hyper-CVAD is widely used to treat acute lymphoblastic leukemia (ALL) and aggressive lymphomas. This multicenter, population-based study assessed the efficacy of Hyper-CVAD as first-line therapy in patients with T-cell ALL (T-ALL). Patient
Autor:
Alicja Markuszewska-Kuczymska, Erik Hulegårdh, Bengt Smedmyr, Maria Åström, Lucia Ahlberg, Piotr Kozlowski, Karin Karlsson, Per Bernell, Hans Hägglund, Helene Hallböök, Beata Tomaszewska-Toporska
Publikováno v:
Haematologica; 97(9), pp 1414-1421 (2012)
Background A minority of patients with adult acute lymphoblastic leukemia who relapse are rescued. The aim of this population-based study was to assess the results of reinduction treatment and allogeneic stem cell transplantation in patients in secon
Autor:
Bengt Smedmyr, Sebastian Giebel, Klaus Geissler, Ulrich Jaeger, Jerzy Holowiecki, Elisabeth Koller, Andrzej Hellmann, Françoise Huguet, Xavier Thomas, Helene Hallböök, Jean-Michel Boiron
Publikováno v:
European Journal of Cancer. 48:360-367
Background Granulocyte-colony stimulating factor (G-CSF) is used to prevent febrile neutropenia and support intense chemotherapy. However, its impact on long-term outcome in oncological patients including adults with acute lymphoblastic leukaemia (AL
Autor:
Thomas H. Tötterman, Gunnar Öberg, Bengt Smedmyr, Bengt Simonsson, Åke Jakobsson, Mats Bengtsson
Publikováno v:
European Journal of Haematology. 46:146-151
In this prospective study we investigated the frequency of CD10+, TdT+ and CD10+ TdT+ mononuclear cells in the bone marrow (BM) and peripheral blood (PB) before and after autologous bone marrow transplantation (ABMT). 49 patients treated for acute ly
Autor:
Bo Nilsson, Håkan Mellstedt, Bengt Smedmyr, H. Gyllenhammar, Bertil Johansson, Richard A. Lerner, Anders Österborg, C. Paul, Gunnar Juliusson, H. Strander, C. Wedelin, Eva Kimby, B. Wadman, G. Brenning, A.-M. Stalfelt, Anders Ahre, G. Gahrton, Andreas Killander, Erik Svedmyr, Magnus Björkholm, Bengt Simonsson, M. Björeman, M. Järnmark, A.-M. Udén
Publikováno v:
European Journal of Haematology. 43:54-62
86 previously untreated patients with multiple myeloma stage III entered a randomized trial comparing combination chemotherapy (VMCP/VBAP) (n = 42) with intermittent oral melphalan and prednisone (MP) treatment (n = 44). The treatment gropus were wel
Autor:
Håkan Mellstedt, Gunnar Juliusson, Eva Ösby, Bengt Simonsson, Bengt Smedmyr, C. Paul, B. Wadman, Bertil Johansson, Erik Svedmyr, H. Strander, Magnus Björkholm, M. Björeman, H. Gyllenhammar, Andreas Killander, Karl Merk, G. Brenning, G. Grimfors, G. Gahrton, A.-M. Stalfelt, Eva Kimby, Richard A. Lerner, M. Järnmark, A.-M. Udén, Anders Österborg, R. Hast
Publikováno v:
European Journal of Haematology. 43:124-128
A randomized study comparing melphalan/prednisone (M/P) therapy with MP + natural alpha-IFN in untreated patients with multiple myeloma stages II and III started April 1, 1986. By March 1989, 78 patients were evaluable in the MP group and 80 in the M
Publikováno v:
European Journal of Haematology. 41:478-481
20 consecutive adult patients with acute lymphoblastic leukemia were treated with an intense induction regimen including vincristine, doxorubicin, prednisolone, L-asparaginase and cyclophosphamide. 16 patients (80%) achieved complete remission and we
Publikováno v:
European Journal of Haematology. 43:167-172
The present study is a retrospective analysis of the outcome in 210 patients diagnosed and treated as having acute lymphoblastic leukaemia (ALL) in Sweden during 1977-84. 131 patients were morphologically rediagnosed as ALL. For the ALL-patients, nin